Keyword

BTLA

Description: BTLA, or B and T lymphocyte attenuator, is an inhibitory immune-checkpoint receptor that regulates lymphocyte activity and is studied in cancer and autoimmunity.
OpenAlex ID: keywords/btla
2005 · Rebecca J. Greenwald, Gordon J. Freeman, et al. · Annual Review of Immunology · 2,384
2017 · Behzad Rowshanravan, Neil Halliday, et al. · Blood · 1,316
2021 · Lukas Kraehenbuehl, Chien-Huan Weng, et al. · Nature Reviews Clinical Oncology · 919
2003 · Norihiko Watanabe, Maya Gavrieli, et al. · Nature Immunology · 900
2003 · Xingxing Zang, P'ng Loke, et al. · Proceedings of the National Academy of Sciences · 408
2017 · Meixiao Long, Kyle Beckwith, et al. · Journal of Clinical Investigation · 406
2008 · Guifang Cai, Anukanth Anumanthan, et al. · Nature Immunology · 360
2014 · N-E Serriari, M Eoche, et al. · Clinical & Experimental Immunology · 346
2006 · Kenneth M. Murphy, Christopher A. Nelson, et al. · Nature reviews. Immunology · 322
2009 · Guifang Cai, Gordon J. Freeman · Immunological Reviews · 318
2010 · Laurent Derré, Jean-Paul Rivals, et al. · Journal of Clinical Investigation · 306
2016 · Michael Boice, Darin Salloum, et al. · Cell · 280
2011 · Marcos W. Steinberg, Timothy C. Cheung, et al. · Immunological Reviews · 261
2014 · Noelle A. Hutchins, Jacqueline Unsinger, et al. · Trends in Molecular Medicine · 254
Works count: 1,276
Citation count: 36,100
Year
Topic
Type